Navigation Links
High Unemployment Rates in North Carolina Will Continue to Dictate the Decrease of Commercial Health Plan Enrollment and the Increase of Medicaid Enrollment
Date:10/28/2010

NASHVILLE, Tenn., Oct. 28 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that high unemployment rates in North Carolina will continue to dictate decreasing commercial health plan enrollment rates and rising Medicaid enrollment rates. However, according to the Carolinas Health Plan Analysis, there is less state funding available to deal with increasing Medicaid enrollment.

The report finds that in order to compensate for this, the state is putting cost-saving measures in place. North Carolina has moved to decrease its drug spending by utilizing a preferred drug list, which will confine drug choices to clinically effective generics and lower-cost alternatives whenever possible. Branded drugs will only be available to recipients on a prior-approval basis. In addition, state legislators have agreed to allow the North Carolina Department of Health and Human Services to enter a multistate purchasing pool to leverage drug rebates and discounts from pharmaceutical companies.

"Compared to other states, North Carolina is late to the table with a preferred drug list," states Jan Shuxteau, market analyst with HealthLeaders-InterStudy. "Pharmaceutical companies will face barriers in the state with prior authorizations and an emphasis on generics. In addition, expect the Department of Health and Human Services to negotiate directly with pharma companies and contract with a pharmacy benefit manager for negotiated discounts and rebates."

Other topics highlighted in the recent Carolinas Health Plan Analysis include:

  • How South Carolina is responding to its increasing Medicaid enrollment.
  • Blue Cross and Blue Shield of North Carolina, the largest plan in the state, and its plan to cut administrative costs by 20 percent.
  • The move by Humana to add the Carolinas HealthCare System to its provider network.

  • Why Pharmaceutical Company Managed Markets Teams Need Health Plan AnalysisHealth Plan Analysis identifies key health plan trends, allowing pharmaceutical companies to create comprehensive strategic plans and sales strategies at state and local levels. Updated quarterly, Health Plan Analysis provides a detailed look at plan design and financials, as well as information about mergers, legislation and other influencers driving healthcare in a particular region.

    About HealthLeaders-InterStudy HealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.

    About Decision Resources, Inc. Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com .

    All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact: Erin O'Leary

    Elizabeth Marshall HealthLeaders-InterStudy

    Decision Resources, Inc. 781-993-2641

    781-993-2563 eoleary@dresources.com

    emarshall@dresources.com
    '/>"/>

    SOURCE HealthLeaders-InterStudy
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Unemployment, Health Care Spending Affect Mortality
    2. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
    3. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
    4. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
    5. GlaxoSmithKline Accelerates Review of Exelixis XL880
    6. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
    7. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
    8. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
    9. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
    10. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
    11. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/19/2017)... The global  pacemaker market  is expected to reach USD 12.3 billion ... heightening prevalence of cardiac conditions coupled with the availability of medical coverage is ... enhancements in these devices are supporting the expansion of this vertical. ... ... Grand View Research Logo ...
    (Date:1/19/2017)... The Global Therapy Partnering Terms and Agreements since 2010 ... agreements entered into by the world,s leading healthcare companies. ... by value - Deals listed by company A-Z, industry ... provides understanding and access to the partnering deals and ... The report provides an analysis of partnering deals. ...
    (Date:1/19/2017)... Jan. 18, 2017 The drug delivery technology ... 2021 from USD 1,179.20 billion in 2016, at a ... prevalence of chronic diseases, increasing demand for biologics, technological ... the growth of this market. Whereas, self-administration & home ... offer significant growth opportunities for players operating in this ...
    Breaking Medicine Technology:
    (Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a heartwarming and ... out for each of his children. “The Angel” is the creation of published author, ... New York City, and impassioned writer. , When asked of her new book, Marjorie ...
    (Date:1/20/2017)... ... ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of ... three in Oklahoma City, and a devoted woman of faith. , “Becoming a parent ... the back of my mind for years, but actually doing it might have been a ...
    (Date:1/19/2017)... ... January 19, 2017 , ... ... Learning Management System: an On-demand E-learning system for Clinical and Regulatory education ... that is based on Aerolib`s successful education methodology of Disease Specific Documentation ...
    (Date:1/19/2017)... ... January 19, 2017 , ... ... innovators, engineers, and scientists from around the world, announces the launch of its ... quick and easy portal to research breakthroughs and trending news, vital information on ...
    (Date:1/19/2017)... ... January 19, 2017 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... Gattefossé, the leader in innovative excipients and drug delivery solutions to health industries ...
    Breaking Medicine News(10 mins):